Orthofix reports Q4 EPS (6c) vs. (75c) last year

Reports Q4 revenue $219.91M, consensus $218.71M. “The fourth quarter capped a year of meaningful operational progress for Orthofix (OFIX),” said Massimo Calafiore, president and CEO. “Throughout 2025, BGT and U.S. Limb Reconstruction delivered strong performance, and the work we did to finalize our Spine commercial channel supported double-digit year-over-year constant currency net sales growth in our global Spine Fixation business. This momentum contributed to our eighth consecutive quarter of adjusted EBITDA growth and a standout quarter of free cash flow generation, clear evidence of the strength of our focused initiatives and margin-enhancement efforts.”